antipyrine has been researched along with Cardiac Remodeling, Ventricular in 4 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Edaravone treatment shifted the %FAC(initial)–%FAC(final) relationship downward (P < 0." | 5.35 | Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats. ( Imai, K; Kawamoto, T; Miyamoto, Y; Neishi, Y; Okura, H; Toyota, E; Yoshida, K, 2009) |
| "During the development of heart failure, edaravone ameliorated the defective interdomain interaction of the RyR2." | 3.73 | Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure. ( Doi, M; Ikeda, Y; Ikemoto, N; Kobayashi, S; Matsuzaki, M; Mochizuki, M; Noma, T; Oda, T; Ohkusa, T; Okuda, S; Tateishi, H; Tokuhisa, T; Yamamoto, T; Yano, M, 2005) |
| "Edaravone treatment shifted the %FAC(initial)–%FAC(final) relationship downward (P < 0." | 1.35 | Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats. ( Imai, K; Kawamoto, T; Miyamoto, Y; Neishi, Y; Okura, H; Toyota, E; Yoshida, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toyota, E | 1 |
| Miyamoto, Y | 1 |
| Imai, K | 1 |
| Neishi, Y | 1 |
| Kawamoto, T | 1 |
| Okura, H | 1 |
| Yoshida, K | 1 |
| Yano, M | 1 |
| Okuda, S | 1 |
| Oda, T | 1 |
| Tokuhisa, T | 1 |
| Tateishi, H | 1 |
| Mochizuki, M | 1 |
| Noma, T | 1 |
| Doi, M | 1 |
| Kobayashi, S | 1 |
| Yamamoto, T | 1 |
| Ikeda, Y | 1 |
| Ohkusa, T | 1 |
| Ikemoto, N | 1 |
| Matsuzaki, M | 1 |
| Onimaru, S | 1 |
| Nakamura, K | 1 |
| Kariyazono, H | 1 |
| Ikeda, R | 1 |
| Ueno, T | 1 |
| Fukumoto, Y | 1 |
| Yabuki, A | 1 |
| Sakata, R | 1 |
| Yamada, K | 1 |
| Onogi, H | 1 |
| Minatoguchi, S | 1 |
| Chen, XH | 1 |
| Bao, N | 1 |
| Kobayashi, H | 1 |
| Misao, Y | 1 |
| Yasuda, S | 1 |
| Yamaki, T | 1 |
| Maruyama, R | 1 |
| Uno, Y | 1 |
| Arai, M | 1 |
| Takemura, G | 1 |
| Fujiwara, H | 1 |
4 other studies available for antipyrine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats.
Topics: Animals; Antipyrine; Consciousness; Disease Models, Animal; Edaravone; Free Radical Scavengers; Hype | 2009 |
Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure.
Topics: Animals; Antioxidants; Antipyrine; Calcium; Cardiac Pacing, Artificial; Dogs; Edaravone; Heart Failu | 2005 |
Inhibitory effects of edaravone on the production of tumor necrosis factor-alpha in the isolated heart undergoing ischemia and reperfusion.
Topics: Analysis of Variance; Animals; Antipyrine; Blood Pressure; Blotting, Western; Edaravone; Free Radica | 2006 |
Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
Topics: Animals; Antipyrine; Blood Pressure; Edaravone; Enzyme Inhibitors; Free Radical Scavengers; Gentisat | 2006 |